2020 journal article

Rapid response of hyperkeratotic erythema multiforme to oclacitinib in two dogs


By: E. High n, K. Linder n, L. Mamo n, B. Levy n, I. Herrmann n & P. Bizikova n

MeSH headings : Animals; Dermatitis, Atopic / drug therapy; Dermatitis, Atopic / veterinary; Dog Diseases / drug therapy; Dogs; Erythema Multiforme / diagnosis; Erythema Multiforme / drug therapy; Erythema Multiforme / veterinary; Female; Pyrimidines / therapeutic use; Skin Diseases / drug therapy; Skin Diseases / veterinary; Sulfonamides / therapeutic use; Treatment Outcome
TL;DR: Oclacitinib could be considered as a fast-acting and effective treatment option for HKEM in dogs with a complete remission of clinical signs observed in 12 and seven weeks in cases 1 and 2. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: May 8, 2020

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of ScienceĀ© and InCitesĀ© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.